Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)
CNY 27.37
(-1.55%)
CNY 27.37
(-1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 57.31 Million | 84.26 Million | 642.07 Million | 217.36 Million | 149.21 Million | 65.46 Million |
| Net Income | 58.87 Million | 163.68 Million | 535.41 Million | 232.57 Million | 136.3 Million | 68.08 Million |
| Depreciation & Amortization | 59.6 Million | 38.74 Million | 25.64 Million | 16.88 Million | 10.53 Million | 7.28 Million |
| Deferred income taxes | 2.83 Million | 20.26 Million | 11.55 Million | 6.1 Million | 2.86 Million | -15.8 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 47.54 Million | -37.17 Million | 79.1 Million | -39.22 Million | -13.71 Million | -10.32 Million |
| Other non-cash items | -39.87 Million | -80.99 Million | 1.91 Million | 7.13 Million | 16.09 Million | 419.43 Thousand |
| Investing Cash Flow | -280.07 Million | -3.31 Billion | -445.92 Million | -147.48 Million | -145.08 Million | -48.65 Million |
| Investments in PPE | -122.98 Million | -242.66 Million | -434.37 Million | -151.76 Million | -140.73 Million | -48.65 Million |
| Acquisitions | - | 0.42 | 25.48 Thousand | 25.94 Thousand | - | 48.65 Million |
| Investment purchases | -300.03 Million | -4.02 Billion | - | -25.94 Thousand | - | -50 Thousand |
| Sales/Maturities of investments | 150 Million | 930 Million | - | 441 Thousand | - | 50.1 Thousand |
| Other Investing Activities | -7.04 Million | 21.43 Million | -11.58 Million | 3.83 Million | -4.34 Million | -48.65 Million |
| Financing Cash Flow | -143.15 Million | 3.41 Billion | 5.21 Million | -81.6 Million | 31.87 Million | -4.86 Million |
| Debt repayment | - | - | -1 Million | - | - | - |
| Dividends payments | -141.62 Million | -134.88 Million | -943.06 | -70.81 Million | -4.86 Million | -4.86 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.52 Million | 3.55 Billion | 6.21 Million | -10.78 Million | 36.74 Million | -4.86 Million |
| Accounts receivables | -97.91 Million | 98.12 Million | -165.72 Million | -137.06 Million | -31.39 Million | -28.99 Million |
| Accounts payables | 147.99 Million | -165.77 Million | 277.21 Million | 114.04 Million | 40.88 Million | 29.94 Million |
| Inventory | -2.53 Million | 10.2 Million | -43.95 Million | -22.3 Million | -26.06 Million | -11.26 Million |
| Other working capital | 150.82 Million | 20.26 Million | 11.55 Million | 6.1 Million | 2.86 Million | 937.16 Thousand |
| Cash at beginning of period | 489.04 Million | 257.94 Million | 57.76 Million | 74.07 Million | 37.7 Million | 26.08 Million |
| Cash at end of period | 108.8 Million | 468.5 Million | 257.94 Million | 57.76 Million | 74.07 Million | 37.7 Million |
| Capital Expenditure | -122.98 Million | -242.66 Million | -434.37 Million | -151.76 Million | -140.73 Million | -48.65 Million |
| Effect of forex changes on cash | 1.37 Million | 24.92 Million | -1.18 Million | -4.58 Million | 354.15 Thousand | -314.34 Thousand |
| Net cash flow / Change in cash | -380.23 Million | 210.56 Million | 200.17 Million | -16.31 Million | 36.36 Million | 11.62 Million |
| Free Cash Flow | -65.67 Million | -158.4 Million | 207.7 Million | 65.6 Million | 8.48 Million | 16.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.66 Million | 24.24 Million | 58.87 Million | 17.2 Million | 8.35 Million | 25.5 Million |
| Depreciation & Amortization | 15.67 Million | 15.67 Million | 59.6 Million | 15.47 Million | -28.62 Million | 14.32 Million |
| Deferred income taxes | - | - | 2.83 Million | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -42.3 Million | - | 47.54 Million | -100.45 Million | 1.07 Million | -1.07 Million |
| Other non-cash items | -4.35 Million | -2.08 Million | -39.87 Million | 31.68 Million | 40.88 Million | -39.18 Million |
| Investing Cash Flow | 12.35 Million | -32.22 Million | -280.07 Million | -26.29 Million | -7.41 Million | 83.77 Million |
| Investments in PPE | -57.44 Million | -32.42 Million | -122.98 Million | -27.24 Million | -8.03 Million | -55.37 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -300.03 Million | - | - | - |
| Sales/Maturities of investments | 70 Million | - | 150 Million | -1.95 Million | - | 141.94 Million |
| Other Investing Activities | -200 Thousand | 200 Thousand | -7.04 Million | 953.45 Thousand | 620 Thousand | -2.79 Million |
| Financing Cash Flow | -49.27 Million | - | -143.15 Million | -8.03 Million | 0.86 | -135.12 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -49.27 Million | - | -141.62 Million | -141.62 Million | - | -135.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -49.27 Million | - | -1.52 Million | 133.59 Million | - | -135.12 Million |
| Accounts receivables | 1.46 Million | - | -97.91 Million | -97.91 Million | -3.24 Million | 3.24 Million |
| Accounts payables | - | - | 147.99 Million | - | - | - |
| Inventory | -43.76 Million | - | -2.53 Million | -2.53 Million | 4.32 Million | -4.32 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 101.63 Million | 108.8 Million | 489.04 Million | 117.96 Million | 90.33 Million | 142.37 Million |
| Cash at end of period | 76.79 Million | 101.63 Million | 108.8 Million | 108.8 Million | 105.04 Million | 90.33 Million |
| Capital Expenditure | -57.44 Million | -32.42 Million | -122.98 Million | -27.24 Million | -8.03 Million | -55.37 Million |
| Effect of forex changes on cash | 1.17 Million | 906.31 Thousand | 1.37 Million | -167.37 Thousand | 427.85 Thousand | 1.68 Million |
| Net cash flow / Change in cash | -24.83 Million | -7.17 Million | -380.23 Million | -9.15 Million | 14.7 Million | -52.04 Million |
| Free Cash Flow | -49.8 Million | -10.26 Million | -65.67 Million | 6.17 Million | 13.66 Million | -55.8 Million |
DKL
MRX
WELSPUNLIV
BEKE
GALD
CHOICEIN